Top Markets
#1 ADO Protocol ADO Protocol +194.13%
#2 GoPlus Security GoPlus Security +39.05%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.18%
#5 Tutorial Tutorial +13.45%
#6 Verus Coin Verus Coin +13.11%
#7 o1.exchange o1.exchange +12.65%
#8 Pons Pons +12.63%
#9 SkyAI SkyAI +11.49%
#10 Status Status +11.24%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
株式のランク #33954
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
株価
$1.83
最終同期: 2026-08-14
時価総額
$6.53M
変化（1日）
-1.61%
変化（1年）
-85.57%
国
US
取引 Cadrenal Therapeutics, Inc. Common Stock (CVKD)

カテゴリー

Healthcare
Cadrenal Therapeutics, Inc. Common Stock（CVKD）の株価履歴
終値の最高値: $1.89 （2026-08-01）

終値の最安値: $46.78 （2023-01-01）
Cadrenal Therapeutics, Inc. Common Stock の株価履歴（2023 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE